Transforming Growth Factor-β Signaling Through the Smad Pathway: Role in Extracellular Matrix Gene Expression and Regulation
Top Cited Papers
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 118 (2) , 211-215
- https://doi.org/10.1046/j.1523-1747.2002.01641.x
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Transforming Growth Factor-β Repression of Matrix Metalloproteinase-1 in Dermal Fibroblasts Involves Smad3Journal of Biological Chemistry, 2001
- Ski-interacting Protein Interacts with Smad Proteins to Augment Transforming Growth Factor-β-dependent TranscriptionPublished by Elsevier ,2001
- Blocking Sp1 Transcription Factor Broadly Inhibits Extracellular Matrix Gene Expression In Vitro and In Vivo: Implications for the Treatment of Tissue FibrosisJournal of Investigative Dermatology, 2001
- Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivatorsOncogene, 2000
- E1A Inhibits Transforming Growth Factor-β Signaling through Binding to Smad ProteinsJournal of Biological Chemistry, 1999
- Role of p300, a transcriptional coactivator, in signalling of TGF‐βGenes to Cells, 1998
- Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-βJournal of Biological Chemistry, 1998
- Human Smad3 and Smad4 Are Sequence-Specific Transcription ActivatorsPublished by Elsevier ,1998
- Regulation of the transforming growth factor-β1 and -β3 promoters by transcription factor SplGene, 1993
- Procollagen gene expression by scleroderma fibroblasts in culture. inhibition of collagen production and reduction of proα(i) and proα1(III) collagen messenger RNA steady‐state levels by retinoidsArthritis & Rheumatism, 1987